JPMorgan Chase & Co. Acquires 66,097 Shares of DocGo Inc. (NASDAQ:DCGO)

JPMorgan Chase & Co. lifted its position in DocGo Inc. (NASDAQ:DCGO) by 151.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 109,855 shares of the company’s stock after buying an additional 66,097 shares during the quarter. JPMorgan Chase & Co. owned about 0.11% of DocGo worth $365,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the company. The Manufacturers Life Insurance Company lifted its stake in shares of DocGo by 31.6% in the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after buying an additional 9,696 shares during the period. Centiva Capital LP bought a new position in DocGo in the 3rd quarter valued at $43,000. WCM Investment Management LLC lifted its position in DocGo by 0.6% during the 3rd quarter. WCM Investment Management LLC now owns 2,626,971 shares of the company’s stock worth $8,879,000 after buying an additional 15,933 shares in the last quarter. Intech Investment Management LLC bought a new position in DocGo in the 3rd quarter worth approximately $62,000. Finally, SG Americas Securities LLC boosted its holdings in DocGo by 97.5% in the third quarter. SG Americas Securities LLC now owns 38,147 shares of the company’s stock valued at $127,000 after acquiring an additional 18,835 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling at DocGo

In other news, General Counsel Ely D. Tendler sold 23,088 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total value of $102,510.72. Following the transaction, the general counsel now directly owns 175,645 shares of the company’s stock, valued at $779,863.80. This represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 2.70% of the company’s stock.

DocGo Stock Up 0.4 %

Shares of DCGO stock opened at $4.80 on Thursday. The company has a market capitalization of $489.84 million, a price-to-earnings ratio of 17.14, a P/E/G ratio of 12.36 and a beta of 0.97. The firm has a fifty day moving average of $4.31 and a 200-day moving average of $3.78. DocGo Inc. has a 12-month low of $2.75 and a 12-month high of $5.05.

DocGo (NASDAQ:DCGO) last announced its earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.04 by $0.01. The business had revenue of $138.68 million during the quarter, compared to analysts’ expectations of $139.59 million. DocGo had a net margin of 4.35% and a return on equity of 8.90%. During the same quarter in the prior year, the company posted $0.05 earnings per share. On average, equities analysts expect that DocGo Inc. will post 0.25 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC restated a “buy” rating and issued a $7.00 price target on shares of DocGo in a research report on Thursday, January 16th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $6.10.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.